US BANCORP \DE\ - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 45 filers reported holding ITERUM THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$1,0000.0%2,0000.0%0.00%
Q4 2021$1,0000.0%2,0000.0%0.00%
Q3 2021$1,000
-80.0%
2,0000.0%0.00%
Q2 2021$5,000
-16.7%
2,000
-50.0%
0.00%
Q1 2021$6,0004,0000.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Canaan Partners X LLC 1,733,170$2,444,0003.33%
New Leaf Venture Partners, L.L.C. 1,456,303$2,053,0000.48%
FRAZIER MANAGEMENT LLC 1,538,316$2,169,0000.17%
Insight Advisors, LLC/ PA 303,500$373,0000.12%
Focused Wealth Management, Inc 75,000$106,0000.02%
FineMark National Bank & Trust 300,000$423,0000.02%
Virtu Financial LLC 133,197$188,0000.01%
XTX Topco Ltd 12,894$18,0000.01%
GRIMES & COMPANY, INC. 124,637$176,0000.01%
HRT FINANCIAL LP 399,479$563,0000.01%
View complete list of ITERUM THERAPEUTICS PLC shareholders